A new study published February 12, 2013 in the Journal of the American Medical Association (JAMA) further confirms the benefits of folic acid when taken by women who are pregnant or who may become pregnant. The study found a link between folic acid intake and reduced rates of autism. Specifically, the study followed more than […]
VICTOZA (liraglutide) – a glucagon-like peptide-1 (GLP-1) receptor agonist commonly used to treat type 2 adult diabetes mellitus. FDA approved uses: Victoza is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Available dosage forms: Solution for subcutaneous injection, prefilled multi-dose pen delivering doses of […]
BYETTA (exenatide) – a glucagon-like peptide-1 (GLP-1) receptor agonist commonly used to treat type 2 adult diabetes mellitus. FDA approved uses: Byetta is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Available dosage forms: Solution for subcutaneous injection, prefilled multi-dose pen delivering doses of […]
On February 8, 2013 the U.S. Food and Drug Administration approved a new drug to treat multiple myeloma. The drug, Pomalyst (pomalidomide) is approved for use in patients whose disease has progressed after being treated with other cancer drugs. Multiple myeloma is a form of blood cancer that primarily affects older adults and arises from […]